We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
-$511K
Cap. Flow
-$4.31M
Cap. Flow %
-1.81%
Top 10 Hldgs %
56.07%
Holding
204
New
16
Increased
9
Reduced
10
Closed
19

Top Buys

Rank Stock Value
1
CDXS icon
Codexis
CDXS
+$1.79M
2
GSK icon
GSK
GSK
+$1.52M
3
FIP icon
FTAI Infrastructure
FIP
+$1.21M
4
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
+$1.01M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$920K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.65M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$3.07M
3
INCY icon
Incyte
INCY
+$2.04M
4
INVA icon
Innoviva
INVA
+$1.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.48M

Sector Composition

Rank Sector Weight
1 Healthcare 32.49%
2 Materials 25.45%
3 Financials 10.86%
4 Real Estate 6.17%
5 Communication Services 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYPH
51
Cypherpunk Technologies Inc
CYPH
$66.7M
$792K 0.33%
90,000
+49,105
+120% +$597K
ARDX icon
52
Ardelyx
ARDX
$1.25B
$774K 0.33%
+650,000
New +$618K
MDLZ icon
53
Mondelez International
MDLZ
$77.9B
$768K 0.32%
14,000
– –
SNY icon
54
Sanofi
SNY
$105B
$760K 0.32%
+20,000
New +$891K
CCOI icon
55
Cogent Communications
CCOI
$612M
$730K 0.31%
14,000
– –
MCRB icon
56
Seres Therapeutics
MCRB
$47M
$706K 0.3%
+5,500
New +$563K
WHWK
57
Whitehawk Therapeutics
WHWK
$183M
$693K 0.29%
49,039
+35,000
+249% +$460K
FNB icon
58
FNB Corp
FNB
$6.71B
$690K 0.29%
59,485
– –
KMB icon
59
Kimberly-Clark
KMB
$37B
$675K 0.28%
6,000
– –
FAZEW
60
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$671K 0.28%
58,321
– –
PCYO icon
61
Pure Cycle
PCYO
$260M
$668K 0.28%
80,000
– –
CTVA icon
62
Corteva
CTVA
$58.6B
$661K 0.28%
11,563
– –
LGV
63
DELISTED
Longview Acquisition Corp. II
LGV
$627K 0.26%
63,900
– –
MTB icon
64
M&T Bank
MTB
$36B
$617K 0.26%
3,500
– –
AUPH icon
65
Aurinia Pharmaceuticals
AUPH
$1.96B
$607K 0.26%
80,694
– –
DD icon
66
DuPont de Nemours
DD
$18.9B
$561K 0.24%
8,872
– –
KO icon
67
Coca-Cola
KO
$362B
$538K 0.23%
9,600
– –
PSTX
68
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$534K 0.22%
+151,286
New +$500K
HVBC
69
DELISTED
HV Bancorp, Inc. Common Stock
HVBC
$519K 0.22%
25,000
– –
MGTX icon
70
MeiraGTx Holdings
MGTX
$1.14B
$507K 0.21%
60,295
+8,545
+17% +$75.3K
DOW icon
71
Dow Inc
DOW
$20.8B
$489K 0.21%
11,136
– –
CDTX
72
DELISTED
Cidara Therapeutics
CDTX
$431K 0.18%
34,301
+2,538
+8% +$35K
MSFT icon
73
Microsoft
MSFT
$2.89T
$373K 0.16%
1,600
– –
ADMA icon
74
ADMA Biologics
ADMA
$1.97B
$370K 0.16%
152,301
– –
IBER
75
DELISTED
Ibere Pharmaceuticals
IBER
$357K 0.15%
36,000
– –
1 2
3
4 5

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return
IWA
Integrity Wealth Advisors Ventura, California $168M AUM 18.33% 1-Year Est. Return

David M. Knott Jr's Q3 2022 Portfolio in Review

As of Q3 2022, David M. Knott Jr held 204 positions worth $238M, down 0.21% from $238M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

David M. Knott Jr's Q3 2022 filing shows 16 new, 9 increased, 10 reduced and 19 closed positions. Its largest new stake was Codexis: 222,107 shares worth $1.35M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $3.65M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Materials and Financials.

  • David M. Knott Jr's largest Q3 2022 buy was Codexis: 222,107 shares worth $1.35M.
  • David M. Knott Jr added most to F-star Therapeutics, Inc. Common Stock in Q3 2022, an estimated $1.01M increase.
  • David M. Knott Jr's biggest Q3 2022 reduction was Incyte, cutting an estimated $2.04M.
  • David M. Knott Jr fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $3.65M.
  • David M. Knott Jr's ten largest holdings make up 56% of its $238M portfolio in Q3 2022.
  • David M. Knott Jr opened 16 new positions and closed 19 in Q3 2022.
  • David M. Knott Jr's portfolio value fell 0.21% quarter-over-quarter to $238M.

Based on David M. Knott Jr's 13F filing for Q3 2022, filed 10 Nov 2022.